Karyopherin α1 inhibitors belong to a class of chemical compounds specifically designed to target and disrupt the activity of the karyopherin α1 protein. Karyopherin α1, also known as Importin α1 or KPNA2, is an essential component of the nuclear transport machinery that facilitates the translocation of various cargo proteins into the cell nucleus. This transport process is crucial for regulating gene expression, cell cycle progression, and maintaining cellular homeostasis. By selectively inhibiting karyopherin α1, these inhibitors aim to interfere with the nuclear import of cargo proteins that rely on this particular importin for their transportation. The design of karyopherin α1 inhibitors often involves meticulous studies of the structural characteristics and functional mechanisms of karyopherin α1. Researchers seek to identify specific binding sites and interactions crucial for its activity in the nuclear import process. Utilizing this knowledge, chemists can then develop small molecules or peptides that selectively bind to karyopherin α1, effectively blocking its interaction with cargo proteins.
Various screening methods, such as high-throughput screening and structure-based drug design, are employed to identify potential karyopherin α1 inhibitors from chemical libraries or natural sources. The identified compounds undergo further optimization to enhance their potency, selectivity, and pharmacokinetic properties. Computational modeling and molecular dynamics simulations also aid in predicting the binding interactions between the inhibitors and karyopherin α1, facilitating the rational design of more effective compounds. Once synthesized and characterized, karyopherin α1 inhibitors are thoroughly tested in vitro using cell-based assays to evaluate their ability to inhibit nuclear import. These assays often involve the use of fluorescently labeled cargo proteins that are dependent on karyopherin α1 for nuclear translocation. The study of karyopherin α1 inhibitors is an active area of research, as these compounds hold great promise for unraveling the complex regulatory networks within cells.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
KPT185 | 1333151-73-7 | sc-487916 | 10 mg | $220.00 | ||
KPT-185 is a synthetic small molecule inhibitor that selectively targets karyopherin α2 (KPNA2). It has shown promising results in research studies on cells for cancer. | ||||||
Verdinexor | 1392136-43-4 | sc-492602 | 5 mg | $395.00 | ||
Verdinexor inhibits CRM1, similar to Leptomycin B, interfering with nuclear export pathways. The inhibition of CRM1 by Verdinexor indirectly influences karyopherin α1, disrupting its role in nucleocytoplasmic transport. The altered nuclear export processes contribute to the modulation of karyopherin α1 function in certain cellular contexts. | ||||||
Mifepristone | 84371-65-3 | sc-203134 | 100 mg | $61.00 | 17 | |
Mifepristone is a glucocorticoid receptor antagonist that indirectly modulates karyopherin α1. By interfering with glucocorticoid receptor signaling pathways, Mifepristone disrupts the import of glucocorticoid receptor complexes mediated by karyopherin α1. This disruption contributes to the modulation of karyopherin α1 function in specific cellular contexts. | ||||||
Ivermectin | 70288-86-7 | sc-203609 sc-203609A | 100 mg 1 g | $57.00 $77.00 | 2 | |
Ivermectin is an antiparasitic agent that has been implicated in modulating nuclear transport. Although its precise target is not fully understood, Ivermectin has been shown to influence karyopherin α1-mediated nuclear import. The specific mechanisms through which Ivermectin affects karyopherin α1 contribute to its modulation in certain cellular contexts. | ||||||
KPT 330 | 1393477-72-9 | sc-489062 | 5 mg | $173.00 | ||
Selinexor inhibits CRM1, similar to Leptomycin B and Verdinexor, disrupting nuclear export pathways. By inhibiting CRM1, Selinexor indirectly influences karyopherin α1, affecting its role in nucleocytoplasmic transport. The disrupted nuclear export processes contribute to the modulation of karyopherin α1 function in certain cellular contexts. | ||||||
Cucurbitacin I | 2222-07-3 | sc-203010 | 1 mg | $250.00 | 9 | |
Cucurbitacin I is a naturally occurring compound found in plants. It has been shown to inhibit karyopherin α2 and disrupt nuclear import in cancer cells. | ||||||
Ranolazine | 95635-55-5 | sc-212769 | 1 g | $109.00 | 3 | |
Ranolazine is an anti-anginal agent in research that has been implicated in modulating nuclear transport. Although its precise target is not fully understood, Ranolazine has been reported to influence karyopherin α1-mediated nuclear import. The specific mechanisms through which Ranolazine affects karyopherin α1 contribute to its modulation in certain cellular contexts. | ||||||